Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Avan

Showing results (281-290 of 462) with videos related to

Pageof 47
Sort By:
Gene|May 6, 2019
Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progressionMaryam Moradi Binabaj, Atena Soleimani, Farzad Rahmani, et al.
International Journal of Cancer|February 8, 2013
Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes backAmir Avan, Paola Pacetti, Michele Reni, et al.
Current Medicinal Chemistry|December 18, 2015
Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted AgentsHamed Mirzaei, Amirhossein Sahebkar, Amir Avan, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistanceOrnella Randazzo, Stella M Cascioferro, Camilla Pecoraro, et al.
Current Drug Targets|March 9, 2019
MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular CarcinomaSeyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, et al.
Computers in Biology and Medicine|February 22, 2023
Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancerNima Zafari, Parsa Bathaei, Mahla Velayati, et al.
Current Pharmaceutical Design|May 7, 2024
Advancing Novel Strategies against Post-surgical Tendon Adhesion Bands, Exploring New FrontiersMaryam Alaei, Doaa Jawad-Kadhim Abdulhasan, Amirhossein Barjasteh, et al.
Molecular Biology Reports|February 24, 2024
Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectivesAmirhossein Bahreyni, Nikoo Saeedi, Abdulridha Mohammed Al-Asady, et al.
BMC Medical Genetics|June 6, 2019
Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndromeSara Kharazmi-Khorassani, Jasmin Kharazmi-Khorassani, Azam Rastegar-Moghadam, et al.
Journal of Clinical Laboratory Analysis|February 25, 2017
Association of tumor necrosis factor-α -308 G/A gene polymorphism with coronary artery diseases: An evidence-based studyElaheh Kazemi, Khadijeh Jamialahmadi, Amir Avan, et al.
Pageof 47

Showing results (281-290 of 462) with videos related to

Sort By:
Pageof 47
Gene|May 6, 2019
Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progressionMaryam Moradi Binabaj, Atena Soleimani, Farzad Rahmani, et al.
International Journal of Cancer|February 8, 2013
Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes backAmir Avan, Paola Pacetti, Michele Reni, et al.
Current Medicinal Chemistry|December 18, 2015
Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted AgentsHamed Mirzaei, Amirhossein Sahebkar, Amir Avan, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistanceOrnella Randazzo, Stella M Cascioferro, Camilla Pecoraro, et al.
Current Drug Targets|March 9, 2019
MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular CarcinomaSeyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, et al.
Computers in Biology and Medicine|February 22, 2023
Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancerNima Zafari, Parsa Bathaei, Mahla Velayati, et al.
Current Pharmaceutical Design|May 7, 2024
Advancing Novel Strategies against Post-surgical Tendon Adhesion Bands, Exploring New FrontiersMaryam Alaei, Doaa Jawad-Kadhim Abdulhasan, Amirhossein Barjasteh, et al.
Molecular Biology Reports|February 24, 2024
Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectivesAmirhossein Bahreyni, Nikoo Saeedi, Abdulridha Mohammed Al-Asady, et al.
BMC Medical Genetics|June 6, 2019
Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndromeSara Kharazmi-Khorassani, Jasmin Kharazmi-Khorassani, Azam Rastegar-Moghadam, et al.
Journal of Clinical Laboratory Analysis|February 25, 2017
Association of tumor necrosis factor-α -308 G/A gene polymorphism with coronary artery diseases: An evidence-based studyElaheh Kazemi, Khadijeh Jamialahmadi, Amir Avan, et al.
Pageof 47